News AstraZeneca abandons plan for £450m vaccine plant in UK In a shock move, AstraZeneca has ditched its plan to invest £450m in a new vaccine manufacturing plant in the UK.
News FDA bans red dye used in medicines over cancer risk The FDA has banned the use of a red dye used in oral medicines, foods and dietary supplements, more than 30 years after it was linked to cancer.
R&D Pharma trends and predictions for 2025: An incoming CEO’s pe... Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape.
News MSD buys Irish vaccines plant from WuXi for €500m MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.
R&D 2025 Life sciences real estate predictions As we commence 2025, for those who are considered leaders or visionaries in their fields, it’s time to dust off the crystal ball and make some bold predictions about what this year will bri
News Novo completes $16.5bn takeover of Catalent Novo Holdings' $16.5bn takeover of US CDMO Catalent has been completed, after months of debate over potential antitrust issues.
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face